These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 32243609

  • 1. The benefits of iron supplementation following blood donation vary with baseline iron status.
    Mast AE, Szabo A, Stone M, Cable RG, Spencer BR, Kiss JE, NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III.
    Am J Hematol; 2020 Jul; 95(7):784-791. PubMed ID: 32243609
    [Abstract] [Full Text] [Related]

  • 2. Oral iron supplementation after blood donation: a randomized clinical trial.
    Kiss JE, Brambilla D, Glynn SA, Mast AE, Spencer BR, Stone M, Kleinman SH, Cable RG, National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study–III (REDS-III).
    JAMA; 2015 Feb 10; 313(6):575-83. PubMed ID: 25668261
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Repeat whole blood donors with a ferritin level of 30 μg/L or less show functional iron depletion.
    Dijkstra A, van den Hurk K, Bilo HJG, Slingerland RJ, Vos MJ.
    Transfusion; 2019 Jan 10; 59(1):21-25. PubMed ID: 30291758
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial.
    Meulenbeld A, Ramondt S, Sweegers MG, Quee FA, Prinsze FJ, Hoogendijk EO, Swinkels DW, van den Hurk K.
    Lancet; 2024 Jul 06; 404(10447):31-43. PubMed ID: 38880108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol.
    Pedrazzini B, Waldvogel S, Cornuz J, Vaucher P, Bize R, Tissot JD, Pecoud A, Favrat B.
    Trials; 2009 Jan 16; 10():4. PubMed ID: 19149890
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Investigation on the feasibility of large-volume autologous red blood cells donation: A pilot trial in a small cohort of Chinese.
    Wu J, Chen G, Wang L, Wang P, Han Y, Yang L, Ouyang X.
    J Clin Apher; 2023 Aug 16; 38(4):447-456. PubMed ID: 36950971
    [Abstract] [Full Text] [Related]

  • 12. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H, Kobayashi Y, Onuma S, Shibagaki K, Yuza T, Hirao K, Yamamoto T, Tomosugi N, Shibata T.
    PLoS One; 2016 Aug 16; 11(3):e0151601. PubMed ID: 26978524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Iron supplementation and blood donation in Nigeria: Effect on Hemoglobin, red cell indices, and iron stores - The ranferon™ study.
    Nwagha TU, Ugwu AO, Nwaekpe CN.
    Ann Afr Med; 2023 Aug 16; 22(1):70-76. PubMed ID: 36695225
    [Abstract] [Full Text] [Related]

  • 16. Iron homeostasis after blood transfusion in stable preterm infants - an observational study.
    Herzlich J, Litmanovitz I, Regev R, Bauer S, Sirota G, Steiner Z, Arnon S.
    J Perinat Med; 2016 Oct 01; 44(8):919-923. PubMed ID: 26992200
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors.
    Spencer BR, Haynes JM, Notari EP, Stramer SL.
    Transfusion; 2020 Apr 01; 60(4):759-768. PubMed ID: 32073674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.
    Am J Kidney Dis; 1997 Dec 01; 30(6):912-22. PubMed ID: 9398141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.